连续体温监测用于血液肿瘤患者发热检测：两种可穿戴设备的初步研究（THERMAL）

This pilot study explored the acceptability and feasibility of two continuous temperature monitoring devices, CORE and TempTraq , in 15 inpatients at risk of neutropenic fever (NF) or cytokine release syndrome (CRS) after chemotherapy, stem cell transplant or chimeric antigen receptor (CAR) T cells. Each device was worn for a median of 95% of the study, correlated with tympanic temperature and exhibited potential for early detection of NF or CRS (ClinicalTrials.gov NCT05203809).